LESLEY REYES: Open Payments
NPI 1003691403 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 40 payments from 14 companies in 2025. Trend: 2023 $223 · 2024 $1,745 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $217 |
| Novo Nordisk Inc | 9 | $187 |
| Amgen Inc. | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $35 |
| SHIELD THERAPEUTICS INC | 2 | $34 |
| ABBVIE INC. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Ascensia Diabetes Care Us Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $25 |
Products named: ELIQUIS, Ozempic, NURTEC ODT, REPATHA, JARDIANCE, Rybelsus, ACCRUFER, GEMTESA.
Industry payments across SC — which companies pay providers there.
